Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Dent disease: A window into calcium and phosphate transport.

Anglani F, Gianesello L, Beara-Lasic L, Lieske J.

J Cell Mol Med. 2019 Aug 31. doi: 10.1111/jcmm.14590. [Epub ahead of print] Review.

2.

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

Fervenza FC, Appel GB, Barbour SJ, Rovin BH, Lafayette RA, Aslam N, Jefferson JA, Gipson PE, Rizk DV, Sedor JR, Simon JF, McCarthy ET, Brenchley P, Sethi S, Avila-Casado C, Beanlands H, Lieske JC, Philibert D, Li T, Thomas LF, Green DF, Juncos LA, Beara-Lasic L, Blumenthal SS, Sussman AN, Erickson SB, Hladunewich M, Canetta PA, Hebert LA, Leung N, Radhakrishnan J, Reich HN, Parikh SV, Gipson DS, Lee DK, da Costa BR, Jüni P, Cattran DC; MENTOR Investigators.

N Engl J Med. 2019 Jul 4;381(1):36-46. doi: 10.1056/NEJMoa1814427.

PMID:
31269364
3.

Recurrent Calcium Kidney Stones.

Beara-Lasic L, Goldfarb DS.

Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1388-1390. doi: 10.2215/CJN.02550319. Epub 2019 Jun 20. No abstract available.

PMID:
31221735
4.

A Twin Study of Genetic Influences on Nephrolithiasis in Women and Men.

Goldfarb DS, Avery AR, Beara-Lasic L, Duncan GE, Goldberg J.

Kidney Int Rep. 2018 Nov 29;4(4):535-540. doi: 10.1016/j.ekir.2018.11.017. eCollection 2019 Apr.

5.

Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts.

Beara-Lasic L, Cogal A, Mara K, Enders F, Mehta RA, Haskic Z, Furth SL, Trachtman H, Scheinman SJ, Milliner DS, Goldfarb DS, Harris PC, Lieske JC; investigators of the Rare Kidney Stone Consortium.

Pediatr Nephrol. 2019 Mar 10. doi: 10.1007/s00467-019-04210-0. [Epub ahead of print]

PMID:
30852663
6.

Dent Disease.

Lieske JC, Milliner DS, Beara-Lasic L, Harris P, Cogal A, Abrash E.

In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019.
2012 Aug 9 [updated 2017 Dec 14].

7.

Glomerular Pathology in Dent Disease and Its Association with Kidney Function.

Wang X, Anglani F, Beara-Lasic L, Mehta AJ, Vaughan LE, Herrera Hernandez L, Cogal A, Scheinman SJ, Ariceta G, Isom R, Copelovitch L, Enders FT, Del Prete D, Vezzoli G, Paglialonga F, Harris PC, Lieske JC; Investigators of the Rare Kidney Stone Consortium.

Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2168-2176. Epub 2016 Oct 3.

8.

Hereditary causes of kidney stones and chronic kidney disease.

Edvardsson VO, Goldfarb DS, Lieske JC, Beara-Lasic L, Anglani F, Milliner DS, Palsson R.

Pediatr Nephrol. 2013 Oct;28(10):1923-42. doi: 10.1007/s00467-012-2329-z. Epub 2013 Jan 20. Review.

9.

Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy.

Surindran S, Ayalon R, Hasan N, Beck LH Jr, Salant DJ, Barisoni L, Skolnik EY, Beara-Lasic L.

Clin Kidney J. 2012 Apr;5(2):162-165. Epub 2012 Mar 9.

10.

Advances in the management of gout: critical appraisal of febuxostat in the control of hyperuricemia.

Beara-Lasic L, Pillinger MH, Goldfarb DS.

Int J Nephrol Renovasc Dis. 2010;3:1-10. Epub 2010 Feb 9.

11.

The effect of big endothelin-1 in the proximal tubule of the rat kidney.

Beara-Lasić L, Knotek M, Cejvan K, Jaksić O, Lasić Z, Skorić B, Brkljacić V, Banfić H.

Br J Pharmacol. 1997 Feb;120(4):625-30.

Supplemental Content

Loading ...
Support Center